Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

BACKGROUND: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. METHODS: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet Glob Health
Autors principals: Murphy, Adrianna, Palafox, Benjamin, O'Donnell, Owen, Stuckler, David, Perel, Pablo, AlHabib, Khalid F, Avezum, Alvaro, Bai, Xiulin, Chifamba, Jephat, Chow, Clara K, Corsi, Daniel J, Dagenais, Gilles R, Dans, Antonio L, Diaz, Rafael, Erbakan, Ayse N, Ismail, Noorhassim, Iqbal, Romaina, Kelishadi, Roya, Khatib, Rasha, Lanas, Fernando, Lear, Scott A, Li, Wei, Liu, Jia, Lopez-Jaramillo, Patricio, Mohan, Viswanathan, Monsef, Nahed, Mony, Prem K, Puoane, Thandi, Rangarajan, Sumathy, Rosengren, Annika, Schutte, Aletta E, Sintaha, Mariz, Teo, Koon K, Wielgosz, Andreas, Yeates, Karen, Yin, Lu, Yusoff, Khalid, Zatońska, Katarzyna, Yusuf, Salim, McKee, Martin
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905400/
https://ncbi.nlm.nih.gov/pubmed/29433667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2214-109X(18)30031-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars